IBT — International Biotechnology Trust Income Statement
0.000.00%
Last trade - 00:00FinancialsConservativeSmall Cap
- £209.23m
- £221.62m
- £44.54m
Annual income statement for International Biotechnology Trust, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 57 | 32.1 | -18 | 12.1 | 44.5 |
| Cost of Revenue | |||||
| Gross Profit | 54.6 | 29.1 | -21.1 | 8.49 | 40.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 3.43 | 4.05 | 4.36 | 5.13 | 5.53 |
| Operating Profit | 53.6 | 28 | -22.3 | 6.93 | 39 |
| Net Income Before Taxes | 53.6 | 28 | -22.3 | 6.93 | 39 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 53.4 | 27.9 | -22.5 | 6.81 | 38.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 53.4 | 27.9 | -22.5 | 6.81 | 38.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 53.4 | 27.9 | -22.5 | 6.81 | 38.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.39 | 0.689 | -0.547 | 0.168 | 1.02 |
| Dividends per Share |